openPR Logo
Press release

United States Biopharmaceutical Fermentation Systems Market 2025 | Growth Drivers, Market Forecast, Competitive Landscape & Business Opportunities

10-06-2025 08:54 AM CET | Health & Medicine

Press release from: DataM intelligence 4 Market Research LLP

Biopharmaceutical Fermentation Systems Market

Biopharmaceutical Fermentation Systems Market

Market Size and Growth

The global biopharmaceutical fermentation systems market is estimated to reach at a high CAGR of 5,9% during the forecast period 2024-2031.

Key Development:

United States: Recent Biopharmaceutical Fermentation Developments

✅ In September 2025, the U.S. biopharmaceutical fermentation systems market was projected to reach $26.6 billion, reflecting an 8.1% growth from 2024. This surge is attributed to increased demand for biologics and advancements in manufacturing technologies.

✅ In August 2025, ProBio launched an end-to-end adeno-associated virus (AAV) production facility in New Jersey. The site supports scalable manufacturing with batch sizes ranging from 50 L to 200 L, accommodating both early and late-phase clinical needs.

✅ In June 2025, Ecolab Life Sciences introduced the Purolite AP+50 affinity chromatography resin at the BIO International Convention in Boston. This innovation enhances antibody manufacturing processes by optimizing operations.

Japan: Recent Biopharmaceutical Fermentation Developments

✅ In September 2025, Japanese biotech firm Fermenta secured ¥2 billion in Series A funding to produce rare natural compounds through fermentation. A pilot plant is scheduled for completion in 2026.

✅ In August 2025, Japan's AMED announced a "Double Match Up" grant program for biopharma startups. The initiative offers up to ¥6.7 billion in grants, matching venture capital investments to support pharmaceutical development pipelines.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/biopharmaceutical-fermentation-systems-market?sb

Recent Mergers and Acquisitions :

United States: Recent M&A in Biopharmaceutical Fermentation

✅ In August 2025, Roche announced the acquisition of 89bio for $3.5 billion. This strategic move aims to bolster Roche's pipeline in metabolic diseases, particularly focusing on 89bio's lead asset, pegozafermin, currently in clinical trials for treating obesity-related conditions.

✅ In January 2025, Roche completed its acquisition of Poseida Therapeutics for approximately $1.5 billion. Poseida specializes in allogeneic CAR-T cell therapies, enhancing Roche's capabilities in advanced cell therapy solutions.

✅ In December 2022, MilliporeSigma, a U.S.-based life sciences company, acquired Erbi Biosystems Inc. This acquisition integrated Erbi's Breez micro-bioreactor platform technology, facilitating scalable cell-based perfusion bioreactor processes and promoting innovation in continuous bioprocessing.

Key Players:

=> Corning, Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Sartorius StedimBiotech, Merck KGaA (Merck Millipore), Eppendorf AG, 3M Company., Nova Biomedicals, Lonza, and Repligen Corporation.
Growth Forecast Projected:

The Global Biopharmaceutical fermentation systems Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Biopharmaceutical fermentation systems Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=biopharmaceutical-fermentation-systems-market

Key Segments:

➥ By Product: Upstream Products, Downstream Products

➥ By Application: Monoclonal Antibodies, Recombinant Proteins, Antibiotics, Probiotics

➥ By End-User: Biopharmaceutical Companies, Contract Manufacturing Organizations, Contract Research Organizations, Academic Research Institutes, Food Industry

Regional Analysis for Biopharmaceutical fermentation systems Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Biopharmaceutical fermentation systems producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Biopharmaceutical fermentation systems revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/biopharmaceutical-fermentation-systems-market?sb

FAQ

Q: What is the growth rate of the Biopharmaceutical fermentation systems Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 5,9% during the forecast period from 2024 to 2031.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release United States Biopharmaceutical Fermentation Systems Market 2025 | Growth Drivers, Market Forecast, Competitive Landscape & Business Opportunities here

News-ID: 4208673 • Views:

More Releases from DataM intelligence 4 Market Research LLP

United States Bladder Cancer Vaccines Market 2025 | Growth Drivers, Key Players & Investment Opportunities
United States Bladder Cancer Vaccines Market 2025 | Growth Drivers, Key Players …
Market Size and Growth The Global Bladder Cancer Vaccines market reached US$254 million in 2024, up from US$209 million in 2023, and is projected to reach US$1,446 million by 2033, growing at a robust CAGR of 21.32% from 2025 to 2033. Key Development & Recent Mergers and acquisitions: United States: Recent Industry Developments ✅ In September 2025, the U.S. FDA approved the Gemcitabine intravesical system (InlexzoTM), previously TAR-200, for adult patients with BCG-unresponsive
United States Peptide Synthesis Market 2025 | Growth Drivers, Key Players & Investment Opportunities
United States Peptide Synthesis Market 2025 | Growth Drivers, Key Players & Inve …
Market Size and Growth The Global Peptide Synthesis market reached US$ 780.00 million in 2023, with a rise to US$ 860.99 million in 2024, and is expected to reach US$ 2,268.16 million by 2033, growing at a CAGR of 11.4% during the forecast period 2025-2033. Key Development: United States: Recent Industry Developments ✅ In October 2025, Cambrex announced a US $120 million investment to expand its API and peptide-manufacturing capacity at its Charles
United States Vaccine Adjuvants Market to hit $1,280.35 million by 2033 - Exclusive Report by DatamIntelligence
United States Vaccine Adjuvants Market to hit $1,280.35 million by 2033 - Exclus …
"The global vaccine adjuvants market size reached US$ 703.15 Million in 2024 from US$ 661.09 Million in 2023 and is expected to reach US$ 1,280.35 Million by 2033, growing at a CAGR of 6.9% during the forecast period 2025-2033." As per DataM intelligence research report Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/vaccine-adjuvants-market United States: Recent Industry Developments ✅ In June 2025, the U.S. vaccine adjuvants market reached around
United States Sterile Injectables Market to hit $1,072.97 million by 2033 - Exclusive Report by DatamIntelligence
United States Sterile Injectables Market to hit $1,072.97 million by 2033 - Excl …
"The Global Sterile Injectables Market reached US$ 542.79 Million with a rise of US$ 578.61 Million in 2024 and is expected to reach US$ 1072.97 Million by 2033, growing at a CAGR of 7.15% during the forecast period 2025-2033." As per DataM intelligence research report Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/sterile-injectable-market?sp United States: Recent Industry Developments ✅ In September 2025, Pfizer Inc. expanded its sterile injectables manufacturing

All 5 Releases


More Releases for Biopharmaceutical

Biopharmaceutical third-party logistics Market
Biopharmaceutical Third-Party Logistics Market to reach over USD 176.28 billion by the year 2031 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biopharmaceutical Third-Party Logistics Market Size, Share & Trends Analysis Report By Supply Chain (Cold Chain, Non-cold Chain), By Service Type (Transportation, Warehousing & Storage), Region, Market Outlook And Industry Analysis 2031" The global Biopharmaceutical third-party logistics market
Biopharmaceutical Fermentation Market Fueling Biopharmaceutical Innovation: The …
Biopharmaceutical Fermentation Market Worth USD 14.91billion by the year 2030- Exclusive Report by InsightAce Analytic The newly published report titled "Global Biopharmaceutical Fermentation Market (By Product (Upstream And Downstream Processes), Application (Antibiotics, Recombinant Proteins, Monoclonal Antibodies, Probiotics, And Others), End-User (Biopharmaceutical Industries, Contract Research Organizations, Food Industries, Academic Research Institutes, And Others))- Trends, Industry Competition Analysis, Covid-19 Analysis, Revenue (US$ Billions) And Forecast Till 2030." of InsightAce Analytic Pvt. Ltd.
Biopharmaceutical Cold Chain Transport Market Temperature-controlled Transport f …
Biopharmaceutical Cold Chain Transport Market 2023 Forecast: Unveiling Opportunities and Growth Biopharmaceutical Cold Chain Transport Market research report helps to recognize the market challenges and opportunities. Global Biopharmaceutical Cold Chain Transport Market report contains the recent forecast research for the predicted period. The report extensively offers the latest information about the technological developments and market growth prospect on the basis of the regional landscape. This Report offers a complete evaluation of
Biopharmaceutical Transport Market Transport Se rvices for Biopharmaceutical Pro …
Biopharmaceutical Transport Market 2023 Forecast: Unveiling Opportunities and Growth Biopharmaceutical Transport Market research report helps to recognize the market challenges and opportunities. Global Biopharmaceutical Transport Market report contains the recent forecast research for the predicted period. The report extensively offers the latest information about the technological developments and market growth prospect on the basis of the regional landscape. This Report offers a complete evaluation of every area including the volume of
Biopharmaceutical Market Industry Analysis - Biopharmaceutical Market Size Drive …
Acumen Research and Consulting has recently published a research report on the Biopharmaceutical Market for the forecast period of 2022 - 2030, wherein, the global market has been analyzed and assessed in an extremely comprehensive manner. The research report on the Biopharmaceutical Market offers an extensive analysis of how the postoperative pain therapeutics landscape would evolve through 2030. The research study on the Biopharmaceutical Market analyzes key drivers upholding product sales
Biopharmaceutical CMO and CRO Market
The Biopharmaceutical CMO and CRO Market crossed US$ 32.25 billion in 2022 and is expected to hit US$ 54.13 billion by 2030, recording a CAGR of 6.5% during the forecast period Pharmaceutical and biotech companies focus on R&D activities to innovate new molecules and therapeutic platforms to deal with chronic diseases and rare ailments; they also extensively invest in R&D activities to develop various therapeutic applications with strong medical and commercial